Research Article
Plasma IL-37 Elevated in Patients with Chronic Heart Failure and Predicted Major Adverse Cardiac Events: A 1-Year Follow-Up Study
Table 2
Cox regression analysis for major adverse cardiac events.
| Variables | Univariate analysis | Multivariable analysis | Hazard ratio | Hazard ratio | (95% CI) | value | (95% CI) | value |
| Age (years) | 0.974 (0.944–1.005) | 0.098 | | | Male, n (%) | 0.647 (0.342–1.225) | 0.181 | | | BMI (kg/m2) | 1.179 (1.010–1.376) | 0.037 | 1.301 (1.042–1.623) | 0.020 | IHD, n (%) | 1.489 (0.774–2.865) | 0.233 | | | Hypertension, n (%) | 1.272 (0.679–2.384) | 0.452 | | | DM, n (%) | 2.797 (1.435–5452) | 0.003 | 3.077 (1.435–5.452) | 0.027 | LVEF (%) | 0.800 (0.749–0.854) | <0.001 | 0.925 (0.848–1.009) | 0.077 | hs-TnT (pg/ml) | 1.097 (1.060–1.136) | <0.001 | | | hs-CRP (ng/ml) | 1.982 (1.539–2.553) | <0.001 | | | NT-proBNP (pg/ml) | 1.001 (1.001–1.001) | <0.001 | 1.001 (1.000–1.001) | <0.001 | IL-37 (pg/ml) | 1.053 (1.043–1.064) | <0.001 | 1.038 (1.017–1.059) | <0.001 |
|
|